Royal Bank of Canada’s Armata Pharmaceuticals ARMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-176
| Closed | – | – | 6824 |
|
|
2024
Q2 | $0 | Buy |
176
+150
| +577% | +$428 | ﹤0.01% | 7015 |
|
|
2024
Q1 | $0 | Sell |
26
-256
| -91% | -$927 | ﹤0.01% | 6989 |
|
|
2023
Q4 | $1K | Buy |
282
+264
| +1,467% | +$623 | ﹤0.01% | 6889 |
|
|
2023
Q3 | $0 | Hold |
18
| – | – | ﹤0.01% | 7054 |
|
|
2023
Q2 | $0 | Buy |
+18
| New | +$26 | ﹤0.01% | 7222 |
|
|
2022
Q4 | – | Sell |
-134
| Closed | -$1K | – | 7198 |
|
|
2022
Q3 | $1K | Buy |
134
+91
| +212% | +$366 | ﹤0.01% | 7140 |
|
|
2022
Q2 | $0 | Hold |
43
| – | – | ﹤0.01% | 7345 |
|
|
2022
Q1 | $0 | Hold |
43
| – | – | ﹤0.01% | 7713 |
|
|
2021
Q4 | $0 | Hold |
43
| – | – | ﹤0.01% | 7632 |
|
|
2021
Q3 | $0 | Sell |
43
-2
| -4% | -$8 | ﹤0.01% | 7609 |
|
|
2021
Q2 | $0 | Sell |
45
-5
| -10% | -$21 | ﹤0.01% | 7460 |
|
|
2021
Q1 | $0 | Sell |
50
-3
| -6% | -$15 | ﹤0.01% | 7400 |
|
|
2020
Q4 | $0 | Sell |
53
-57
| -52% | -$181 | ﹤0.01% | 7051 |
|
|
2020
Q3 | $0 | Hold |
110
| – | – | ﹤0.01% | 6593 |
|
|
2020
Q2 | $0 | Hold |
110
| – | – | ﹤0.01% | 6604 |
|
|
2020
Q1 | $0 | Hold |
110
| – | – | ﹤0.01% | 6644 |
|
|
2019
Q4 | $0 | Sell |
110
-50
| -31% | -$201 | ﹤0.01% | 6800 |
|
|
2019
Q3 | $0 | Buy |
160
+110
| +220% | +$433 | ﹤0.01% | 6680 |
|
|
2019
Q2 | $0 | Sell |
50
-1
| -2% | -$4 | ﹤0.01% | 6847 |
|
|
2019
Q1 | $0 | Hold |
51
| – | – | ﹤0.01% | 6786 |
|
|
2018
Q4 | $0 | Hold |
51
| – | – | ﹤0.01% | 6724 |
|
|
2018
Q3 | $1K | Hold |
51
| – | – | ﹤0.01% | 6580 |
|
|
2018
Q2 | $1K | Hold |
51
| – | – | ﹤0.01% | 6328 |
|
|
2018
Q1 | $1K | Hold |
51
| – | – | ﹤0.01% | 6181 |
|
|
2017
Q4 | $1K | Hold |
51
| – | – | ﹤0.01% | 6358 |
|
|
2017
Q3 | $1K | Hold |
51
| – | – | ﹤0.01% | 6607 |
|
|
2017
Q2 | $1K | Hold |
51
| – | – | ﹤0.01% | 6365 |
|
|
2017
Q1 | $3K | Hold |
51
| – | – | ﹤0.01% | 6333 |
|
|
2016
Q4 | $3K | Buy |
51
+37
| +264% | +$4.6K | ﹤0.01% | 6401 |
|
|
2016
Q3 | $3K | Hold |
14
| – | – | ﹤0.01% | 6081 |
|
|
2016
Q2 | $3K | Buy |
14
+7
| +100% | +$2.42K | ﹤0.01% | 6049 |
|
|
2016
Q1 | $4K | Buy |
+7
| New | +$3.59K | ﹤0.01% | 5960 |
|
Other funds holding ARMP
BCM
SWM
Royal Bank of Canada's ARMP Position: Q3 2024 in Review
Royal Bank of Canada sold out of Armata Pharmaceuticals (ARMP) in Q3 2024, closing a stake of 176 shares.
Royal Bank of Canada first reported a position in ARMP in Q1 2016 and held it in 32 quarters. The position peaked at $4K in Q1 2016. 24 funds tracked by Wall St. Rank hold ARMP as of Q3 2024.
- Royal Bank of Canada reported no remaining Armata Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
- Royal Bank of Canada sold 176 Armata Pharmaceuticals shares in Q3 2024.
- Royal Bank of Canada first reported a position in Armata Pharmaceuticals in Q1 2016 and held it in 32 quarters.
- Royal Bank of Canada's Armata Pharmaceuticals position peaked at $4K in Q1 2016.
- 24 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q3 2024.
Based on Royal Bank of Canada's 13F filing for Q3 2024, filed 14 Nov 2024.